Atlas Trials

Chronic Idiopathic Urticaria

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Idiopathic Urticaria

RecordFirmDate
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases (NCT03858634)Genentech, Inc.2019-05-29
Mast Cell Activation Test in Allergic Disease (NCT03406325)Hong Kong Sanatorium & Hospital2018-02-01
Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody (NCT03183024)Jonathan A. Bernstein, MD2017-09-12
Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria (NCT02814630)Asthma Inc Clinical Research Center2016-09-01
Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria (NCT02166151)Rabin Medical Center2014-07-01
Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines (NCT02031679)Johns Hopkins University2014-01-01
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients (NCT01803763)Insel Gruppe AG, University Hospital Bern2012-09-01
Efficacy Study of Canakinumab to Treat Urticaria (NCT01635127)University of Zurich2012-06-01
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment (NCT01599637)Novartis Pharmaceuticals2012-04-01
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) (NCT01292473)Genentech, Inc.2011-03-01
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists (NCT01264939)Genentech, Inc.2011-02-01
A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment (NCT01287117)Genentech, Inc.2011-02-01
Etanercept for the Treatment of Chronic Urticaria (NCT01030120)University of Utah2010-12-01
A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) (NCT00866788)Genentech, Inc.2009-03-01
Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849) (NCT00536380)Organon and Co2007-09-01
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria (NCT00346606)Lotus Pharmaceutical2006-01-01
CUTE (Chronic Urticaria Treatment Evaluation) (NCT00264303)UCB Pharma2005-12-01
A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) (NCT00783354)Organon and Co2003-04-01
Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994) (NCT00757562)Organon and Co2002-11-01

Track Chronic Idiopathic Urticaria automatically

Every clearance here is in the API, with alerts when new ones post.